Avidity Biosciences, Inc. (30)

Browse by Contract Category

Contracts

General Release of Claims, dated August 30, 2021, by and between Avidity Biosciences, Inc. and Jae B. Kim, M.D (Filed With SEC on November 9, 2021)
Sales Agreement, dated July 2, 2021, between Avidity Biosciences, Inc. and Cowen and Company, LLC (Filed With SEC on July 2, 2021)
Amended and Restated Lease Agreement, dated December 18, 2020, by and between ARE-SD Region No. 44, LLC and the Registrant (Filed With SEC on March 15, 2021)
Employment Agreement, dated December 8, 2020, by and between W. Michael Flanagan, Ph.D. and the Registrant (Filed With SEC on March 15, 2021)
Description of Registered Securities (Filed With SEC on March 15, 2021)
Underwriting Agreement, dated August 3, 2021, by and among Avidity Biosciences, Inc. and Cowen and Company, LLC, SVB Leerink LLC, Evercore Group L.L.C., and Wells Fargo... (Filed With SEC on August 4, 2021)
Non-Employee Director Compensation Program (Filed With SEC on March 15, 2021)
Employment Agreement, dated July 6, 2020, by and between Jae B. Kim, M.D., and Avidity Biosciences, Inc (Filed With SEC on November 10, 2020)
Lease Agreement, dated June 1, 2020, by and between ARE-SD Region No. 44, LLC and Registrant (Filed With SEC on June 8, 2020)
Lease Agreement, dated March 31, 2014, as amended, by and between ARE-10933 North Torrey Pines, LLC and Registrant (Filed With SEC on June 8, 2020)
Non-Employee Director Compensation Program (Filed With SEC on June 8, 2020)
Avidity Biosciences, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on June 8, 2020)
Avidity Biosciences, Inc. 2020 Incentive Award Plan, including form of stock option grant notice and stock option agreement thereunder (Filed With SEC on June 8, 2020)
Lease Agreement, dated March 31, 2014, as amended, by and between ARE-10933 North Torrey Pines, LLC and Registrant (Filed With SEC on May 22, 2020)
Form of Underwriting Agreement (Filed With SEC on May 22, 2020)
Specimen stock certificate evidencing the shares of common stock (Filed With SEC on May 22, 2020)
Research Collaboration and License Agreement, dated April 17, 2019, by and between Eli Lilly and Company and the Registrant (Filed With SEC on May 22, 2020)
Form of Indemnification Agreement for Directors and Officers (Filed With SEC on May 22, 2020)
Release Agreement dated December 19, 2019, by and between P. Kent Hawryluk and the Registrant (Filed With SEC on May 22, 2020)
Executive Chairman Agreement, dated October 28, 2019, by and between Troy Wilson, Ph.D., J.D. and the Registrant (Filed With SEC on May 22, 2020)
Employment Letter Agreement, dated May 14, 2020, by and between Michael F. MacLean and the Registrant (Filed With SEC on May 22, 2020)
Employment Letter Agreement, dated May 15, 2020, by and between Arthur A. Levin, Ph.D. and the Registrant (Filed With SEC on May 22, 2020)
Employment Letter Agreement, dated May 15, 2020, by and between Joseph Baroldi and the Registrant (Filed With SEC on May 22, 2020)
Employment Letter Agreement, dated May 15, 2020, by and between Sarah Boyce and the Registrant (Filed With SEC on May 22, 2020)
Avidity Biosciences, Inc. 2013 Amended and Restated Equity Incentive Plan, including form of stock option grant notice and stock option agreement thereunder (Filed With SEC on May 22, 2020)
Warrant issued to Silicon Valley Bank, dated June 9, 2017 (Filed With SEC on May 22, 2020)
Warrant issued to Silicon Valley Bank, dated August 7, 2015 (Filed With SEC on May 22, 2020)
Participation Rights Letter Agreement, dated November 8, 2019, by and among RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd. and RTW Venture Fund Limited (Filed With SEC on May 22, 2020)
Amended and Restated Registration Rights Agreement, dated November 8, 2019, by and among the Registrant and certain of its stockholders (Filed With SEC on May 22, 2020)
Loan and Security Agreement, dated August 7, 2015, as amended, by and between Silicon Valley Bank and the Registrant (Filed With SEC on May 22, 2020)